Tickers

1. Composite Trajectory Verdict

The income statement and cash flow statement matter most for assessing CSL's performance given its cyclical building products model where margin resilience and cash conversion through cycles are key, while the balance sheet reflects aggressive capital return policy.

Composite Trajectory: Mixed

The annual 2025 results show revenue stagnation (+0.3%), operating income decline (-12.3%), margin compression (20.0% vs 22.8%), and a 53% increase in long-term debt funding share repurchases, indicating deterioration. However, the first half of 2026 shows revenue growth (+3.0% YTD), stable operating margins (20.3% vs 20.4% YTD), and rising EPS from continuing operations (+5.1% YTD) aided by share count reduction, providing offsetting improvement signals. Cash flow deteriorated sharply in H1 2026 (operating cash flow -32% YTD) due to working capital builds, while the balance sheet shows permanently higher leverage post-2025 debt issuance.

2. Red Flags

• Operating margin compressed 280 bps YoY to 20.0% in FY2025 despite flat revenue (10-K 2025-12-31, Consolidated Statements of Operations)
• CWT segment operating margin collapsed 560 bps to 7.8% in FY2025 (10-K 2025-12-31, Segment Results)
• Operating cash flow fell 32% YTD to $197.1M in H1 2026 vs $288.9M in H1 2025, driven by $364M receivables build and $125M tax credit settlement (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows; MD&A)
• Long-term debt increased 53% to $2.88B in FY2025 while equity fell 27% to $1.80B, raising debt/equity from 0.77x to 1.61x (10-K 2025-12-31, Consolidated Balance Sheets)
• $1.3B share repurchases in FY2025 largely funded by $988M new note issuance (10-K 2025-12-31, Consolidated Statements of Cash Flows)
• Henry indefinite-lived trade name ($219M carrying value) fair value exceeds carrying value by less than 10%, indicating impairment risk (10-K 2025-12-31, Critical Audit Matter / Note 11)
• Accounts payable surged 75% to $408M at June 30, 2026 from $233M at Dec 31, 2025, signaling seasonal working capital intensity (10-Q 2026-06-30, Condensed Consolidated Balance Sheets)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Overall Assessment: FY2025 revenue was essentially flat at $5,019.9M vs $5,003.6M in FY2024, but operating income fell 12.3% to $1,002.5M and operating margin compressed to 20.0% from 22.8% (10-K 2025-12-31, Consolidated Statements of Operations). Income from continuing operations declined 14.2% to $742.5M, though diluted EPS from continuing operations fell only 6.4% to $17.16 due to an 8.3% reduction in diluted share count (10-K 2025-12-31, Consolidated Statements of Operations). In the first half of 2026, revenue grew 3.0% YTD to $2,622.4M, operating income rose 2.7% to $532.8M, and operating margin was stable at 20.3% vs 20.4% (10-Q 2026-06-30, Condensed Consolidated Statements of Operations). However, income from continuing operations dipped 2.6% YTD to $385.4M while diluted EPS from continuing operations rose 5.1% to $9.43, reflecting continued share repurchases (10-Q 2026-06-30, Condensed Consolidated Statements of Operations). Segment divergence persists: CCM GAAP operating margin declined to 26.9% YTD 2026 from 27.4% YTD 2025, while CWT GAAP operating margin fell to 8.7% from 9.0% (10-Q 2026-06-30, MD&A Segment Results).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Annual operating cash flow has stabilized near $1.1B over three years ($1,201M in 2023, $1,030M in 2024, $1,102M in 2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). Free cash flow (operating less capex) followed a similar pattern: $1,059M, $917M, $971M (10-K 2025-12-31, Consolidated Statements of Cash Flows). However, the first half of 2026 shows significant deterioration: operating cash flow dropped 32% to $197.1M from $288.9M in H1 2025, primarily due to a $364M increase in receivables, $47M inventory build, and a $125M post-year-end tax credit settlement (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows; MD&A). Investing outflows moderated to $70M capex in H1 2026 from $166M in H1 2025 (which included acquisitions) (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows). Financing remains dominated by share repurchases ($500M YTD 2026 vs $700M YTD 2025) and dividends ($90M vs $88M) (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Overall Assessment: The balance sheet shifted markedly in FY2025 with long-term debt rising 53% to $2,881.6M from $1,887.4M following the August 2025 issuance of $1.0B in 2035 and 2040 notes, while total equity fell 27% to $1,795.4M from $2,463.3M due to $1.3B in share repurchases (10-K 2025-12-31, Consolidated Balance Sheets; Consolidated Statements of Cash Flows). Net debt increased to ~$1.77B from ~$1.13B. Goodwill and intangibles remain elevated at $2.96B combined (47% of assets) (10-K 2025-12-31, Consolidated Balance Sheets). As of June 30, 2026, cash declined to $665M from $1,112M at year-end 2025 reflecting $500M YTD repurchases, while receivables surged 61% to $956M and payables rose 75% to $408M, indicating seasonal working capital expansion (10-Q 2026-06-30, Condensed Consolidated Balance Sheets). Debt levels remain elevated at $2,885M with no near-term maturities but higher interest expense ($55.7M YTD 2026 vs $29.5M YTD 2025) (10-Q 2026-06-30, Condensed Consolidated Statements of Operations).

6. Data Gaps

• Q1 2026 and Q3/Q4 2025 standalone quarterly results (only YTD and annual provided) to assess intra-year seasonality and quarterly margin progression
• Full 10-Q filings for 2026-03-31, 2025-09-30, and 2025-06-30 (referenced in document list but not included in provided text) for complete quarterly trend analysis
• Disaggregated free cash flow conversion rate by segment
• Organic revenue growth rate excluding acquisitions for full year 2025 (MD&A provides organic/acquisition split for revenue but not for full year segment operating income)
• Post-2026 debt maturity schedule beyond qualitative statement in 10-K
• Detailed breakdown of "Other current liabilities" increase from $405M to $503M in FY2025 (10-K 2025-12-31, Note 12 shows components but not all drivers)